CFR Pharma Acquisition Of Adcock Ingram Gets Major Endorsement
This article was originally published in PharmAsia News
Executive Summary
Four major investors of South Africa's Adcock Ingram endorsed the proposed $1.3 billion acquisition by CFR Pharmaceuticals of Chile, set to become a major emerging-market drug maker.